-
Something wrong with this record ?
Coordination compounds in cancer: Past, present and perspectives
Federica Trudu, Filippo Amato, Petr Vaňhara, Tiziana Pivetta, E.M. Peña-Méndez, Josef Havel
Language English Country Czech Republic
Document type Research Support, Non-U.S. Gov't, Review
- MeSH
- Cisplatin history pharmacology therapeutic use MeSH
- Gallium history pharmacology therapeutic use MeSH
- Genomics methods trends MeSH
- Precision Medicine methods trends utilization MeSH
- Cobalt history pharmacology therapeutic use MeSH
- Coordination Complexes * pharmacology therapeutic use MeSH
- Humans MeSH
- Copper pharmacology therapeutic use MeSH
- Metabolomics methods trends MeSH
- Interdisciplinary Communication MeSH
- Proteomics methods trends MeSH
- Antineoplastic Agents * pharmacology therapeutic use MeSH
- Ruthenium Compounds history pharmacology therapeutic use MeSH
- Iron Compounds history pharmacology therapeutic use MeSH
- Gold Compounds history pharmacology therapeutic use MeSH
- Statistics as Topic MeSH
- Check Tag
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Metal-based coordination compounds have been used throughout the history of human medicine to treat various diseases, including cancer. Since the discovery of cisplatin in 1965, a great number of metal coordination complexes, such as platinum, ruthenium, gold or copper have been designed, synthesized and tested in order to develop clinically effective and safe drugs. Currently, many reviews cover applications of cytostatic metal complexes pointing out the most promising examples of platinum- and non-platinum-based compounds in preclinical and clinical trials. However, recent comprehensive reviews covering chemical and biological aspects of metal-based coordination compounds in cancer therapy are still rare. In this review we wish to provide an overview of the coordination chemistry of current and novel cytostatic compounds, including an outline of their design and rationale of synthesis, and summarize bio-chemical reactivity and physicochemical properties of candidate metal complexes.
Department of Chemical and Geological Sciences University of Cagliari Monserrato Italy
Department of Chemistry Faculty of Science Masaryk University Brno
Department of Chemistry Faculty of Science University of la Laguna La Laguna Tenerife Spain
Department of Histology and Embryology Faculty of Medicine Masaryk University Brno Czech Republic
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15028322
- 003
- CZ-PrNML
- 005
- 20160214124248.0
- 007
- ta
- 008
- 150902s2015 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2015.03.003 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Trudu, Federica $7 _AN084101 $u Department of Chemistry, Faculty of Science, Masaryk University, Brno; Department of Chemical and Geological Sciences, University of Cagliari, Monserrato (CA), Italy
- 245 10
- $a Coordination compounds in cancer: Past, present and perspectives / $c Federica Trudu, Filippo Amato, Petr Vaňhara, Tiziana Pivetta, E.M. Peña-Méndez, Josef Havel
- 504 __
- $a Literatura
- 520 9_
- $a Metal-based coordination compounds have been used throughout the history of human medicine to treat various diseases, including cancer. Since the discovery of cisplatin in 1965, a great number of metal coordination complexes, such as platinum, ruthenium, gold or copper have been designed, synthesized and tested in order to develop clinically effective and safe drugs. Currently, many reviews cover applications of cytostatic metal complexes pointing out the most promising examples of platinum- and non-platinum-based compounds in preclinical and clinical trials. However, recent comprehensive reviews covering chemical and biological aspects of metal-based coordination compounds in cancer therapy are still rare. In this review we wish to provide an overview of the coordination chemistry of current and novel cytostatic compounds, including an outline of their design and rationale of synthesis, and summarize bio-chemical reactivity and physicochemical properties of candidate metal complexes.
- 650 12
- $a protinádorové látky $x farmakologie $x terapeutické užití $7 D000970
- 650 12
- $a komplexní sloučeniny $x farmakologie $x terapeutické užití $7 D056831
- 650 _2
- $a cisplatina $x dějiny $x farmakologie $x terapeutické užití $7 D002945
- 650 _2
- $a sloučeniny ruthenia $x dějiny $x farmakologie $x terapeutické užití $7 D017975
- 650 _2
- $a sloučeniny zlata $x dějiny $x farmakologie $x terapeutické užití $7 D017612
- 650 _2
- $a měď $x farmakologie $x terapeutické užití $7 D003300
- 650 _2
- $a genomika $x metody $x trendy $7 D023281
- 650 _2
- $a proteomika $x metody $x trendy $7 D040901
- 650 _2
- $a metabolomika $x metody $x trendy $7 D055432
- 650 _2
- $a sloučeniny železa $x dějiny $x farmakologie $x terapeutické užití $7 D058085
- 650 _2
- $a kobalt $x dějiny $x farmakologie $x terapeutické užití $7 D003035
- 650 _2
- $a galium $x dějiny $x farmakologie $x terapeutické užití $7 D005708
- 650 _2
- $a mezioborová komunikace $7 D033183
- 650 _2
- $a individualizovaná medicína $x metody $x trendy $x využití $7 D057285
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a statistika jako téma $7 D013223
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Amato, Filippo $7 _AN074450 $u Department of Chemistry, Faculty of Science, Masaryk University, Brno; Department of Chemical and Geological Sciences, University of Cagliari, Monserrato (CA), Italy
- 700 1_
- $a Vaňhara, Petr, $d 1980- $7 xx0106079 $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Pivetta, Tiziana $u Department of Chemical and Geological Sciences, University of Cagliari, Monserrato (CA), Italy
- 700 1_
- $a Peña-Méndez, E.M. $u Department of Chemistry, Faculty of Science, University of la Laguna, La Laguna, Tenerife, Spain
- 700 1_
- $a Havel, Josef, $d 1940- $7 jk01040227 $u Department of Chemistry, Faculty of Science, Masaryk University, Brno
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 13, č. 2 (2015), s. 79-103 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2015/02/02.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20150522215938 $b ABA008
- 991 __
- $a 20160214124412 $b ABA008
- 999 __
- $a ok $b bmc $g 1089197 $s 911387
- BAS __
- $a 3
- BMC __
- $a 2015 $b 13 $c 2 $d 79-103 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK184 $d 20160214 $a NLK 2015-37/dk